Menu Search
Equities

Shanghai Chicmax Cosmetic Co Ltd

2145:HKG.HS

Shanghai Chicmax Cosmetic Co Ltd

Actions
  • Price (HKD)49.50
  • Today's Change-1.20 / -2.37%
  • Shares traded469.40k
  • 1 Year change+92.23%
  • Beta--
Data delayed at least 15 minutes, as of May 17 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shanghai Chicmax Cosmetic Co Ltd is a China-based multi-brand cosmetics company mainly engaged in the research, development, production and sales of skincare and maternity and childcare products. The Company has brands such as KANS, One Leaf, and Baby Elephant. The KANS focuses on the changing anti-aging needs of Asian women of all ages. The One Leaf focuses on plant technology and environmental protection skin care products for young consumers. The Baby Elephant focuses on specialized maternal and childcare products suitable for the skin of Chinese babies and children. The Company's products include skin care products, maternal and childcare products, toiletries, and others. The Company also operates brands such as BIO-G, KYOCA, ARMIYO, TAZU and others.

  • Revenue in HKD (TTM)4.53bn
  • Net income in HKD498.35m
  • Incorporated2004
  • Employees1.88k
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.